Loading...
Loading...
India's amphotericin imports from UNITED STATES total $5.6M across 61 shipments from 15 foreign suppliers. Gilead Sciences Ireland UC leads with $2.5M in import value; the top 5 suppliers together control 88.1% of this origin. Leading Indian buyers include MYLAN PHARMACEUTICALS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for amphotericin — a diversified sourcing base with multiple active suppliers from UNITED STATES.

Gilead Sciences Ireland UC is the leading Amphotericin supplier from UNITED STATES to India, with import value of $2.5M across 6 shipments. The top 5 suppliers — Gilead Sciences Ireland UC, M/S SUN PHARMACEUTICAL INDUSTRIES INC, ESPEE BIOPHARMA & FINECHEM LLC, DERMA & DERMO COM,PRODS,DERM,FARM LTDA(AMHO), ESPEE BIOPHARMA & FINECHEM LLC. — collectively account for 88.1% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | Gilead Sciences Ireland UC | $2.5M | 6 | 44.2% |
| 2 | M/S SUN PHARMACEUTICAL INDUSTRIES INC | $1.2M | 1 | 21.3% |
| 3 | ESPEE BIOPHARMA & FINECHEM LLC | $556.1K | 11 | 9.9% |
| 4 | DERMA & DERMO COM,PRODS,DERM,FARM LTDA(AMHO) | $500.0K | 3 | 8.9% |
| 5 | ESPEE BIOPHARMA & FINECHEM LLC. | $213.4K | 3 | 3.8% |
| 6 | SUN FARMACEUTICA DO BRASIL LTDA | $185.9K | 1 | 3.3% |
| 7 | Asaman, Inc. | $138.5K | 4 | 2.5% |
| 8 | ASAMAN INC | $93.6K | 4 | 1.7% |
| 9 | AGRACE PHARMA. | $71.8K | 3 | 1.3% |
| 10 | SAVI Clinicals FZ LLC | $37.0K | 1 | 0.7% |
| 11 | SAVI CLINICALS FZ LLC | $30.4K | 3 | 0.5% |
| 12 | ESPEE BIOPHARMA FINECHEM LLC | $25.5K | 1 | 0.5% |
| 13 | DERMA & DERMA COM.PRODS.DERM.FARM.LTDA(AMHO) | $18.7K | 1 | 0.3% |
| 14 | M S SUN FARMACEUTICA DO BRASIL LTDA | $18.6K | 1 | 0.3% |
| 15 | M/S SUN FARMACEUTICA DO BRASIL LTDA | $10.8K | 2 | 0.2% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MYLAN PHARMACEUTICALS PRIVATE LIMITED | $2.5M | 6 | 44.2% |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $1.4M | 5 | 25.1% |
| 3 | SITEC LABS LIMITED | $500.0K | 3 | 8.9% |
| 4 | DR.REDDY'S LABORATORIES LIMITED | $347.9K | 6 | 6.2% |
| 5 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED | $213.4K | 3 | 3.8% |
| 6 | EMCURE PHARMACEUTICALS LIMITED | $202.9K | 5 | 3.6% |
| 7 | MYLAN LABORATORIES LIMITED | $178.6K | 7 | 3.2% |
| 8 | DR.REDDY'S LABORATORIES LTD | $82.6K | 5 | 1.5% |
| 9 | INTAS PHARMACEUTICALS LIMITED | $58.0K | 3 | 1.0% |
| 10 | CLIANTHA RESEARCH LIMITED | $53.5K | 1 | 1.0% |
| 11 | HETERO LABS LIMITED | $37.0K | 1 | 0.7% |
| 12 | CIPLA LIMITED | $18.7K | 1 | 0.3% |
| 13 | EUROFINS ADVINUS LIMITED | $8.9K | 3 | 0.2% |
| 14 | VEEDA CLINICAL RESEARCH LIMITED | $8.6K | 4 | 0.2% |
| 15 | SUN PHARMACEUTICAL MEDICARE LIMITED | $4.8K | 5 | 0.1% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Amphotericin suppliers from UNITED STATES to India include Gilead Sciences Ireland UC, M/S SUN PHARMACEUTICAL INDUSTRIES INC, ESPEE BIOPHARMA & FINECHEM LLC. The leading supplier is Gilead Sciences Ireland UC with import value of $2.5M USD across 6 shipments. India imported Amphotericin worth $5.6M USD from UNITED STATES in total across 61 shipments.
India imported Amphotericin worth $5.6M USD from UNITED STATES across 61 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Amphotericin sourced from UNITED STATES include MYLAN PHARMACEUTICALS PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, SITEC LABS LIMITED. The largest buyer is MYLAN PHARMACEUTICALS PRIVATE LIMITED with $2.5M in imports across 6 shipments.
The total value of Amphotericin imports from UNITED STATES to India is $5.6M USD, across 61 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
61 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists